- Division of Neuroscience, Development and Aging – DNDA
- Molecular, Cellular and Developmental Neuroscience – MDCN
- Study Section:
- Molecular Neuropharmacology and Signaling – MNPS
Dr. Carole Jelsema received her Ph.D. in cell biology from the University of Chicago followed by joint postdoctoral training in both the Department of Cell Biology and Department of Pharmacology at Yale University School of Medicine. After a brief stint as assistant professor at the Medical College of Wisconsin, pharmacology department, she came to NIH as a senior staff fellow in the Laboratory of Cellular Metabolism, Metabolic Regulation Section at the National Heart, Lung and Blood Institute (NHLBI). She subsequently moved to Laboratory of Cell Biology, Neuropharmacology Section at the National Institute of Mental Health. Dr. Jelsema then went to National Institute of Arthritis and Musculoskeletal and Skin Diseases, serving as an Acting Section Chief in the Laboratory of Immunology, Arthritis and Rheumatism Branch. Her research throughout focused on the role of lipids, G proteins and kinases in signal transduction. Dr Jelsema joined CSR as an Scientific Review Officer for a visual sciences study section before becoming the Chief for the Molecular Cellular and Developmental Neurosciences Integrated Review Group.